Skip to content
value.today

DexCom, Inc. and its peers

1 companies side by side: each figure with its date and source, its rank in the group and its percentile in its sector and country.

Companies in the group

Up to 12. Remove or re-base from the table's column heads.

Also: these companies in the compare tool.

Keep this group

Save it for yourself or, in a team, for everyone in it.

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Mettler-Toledo International Inc.MTD · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $32.5 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $32.5 B (Oct 21, 2026) · revenue $4.0 B (year to December 2025)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    + Add
  • Quest Diagnostics IncorporatedDGX · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $27.8 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $27.8 B (Oct 30, 2026) · revenue $11.0 B (year to December 2025)
    100 of 100 (industry or sector 50 + size 30 + country 15 + figures on file 5)
    + Add
  • Labcorp Holdings Inc.LH · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $26.3 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $26.3 B (Oct 22, 2026) · revenue $14.0 B (year to December 2025)
    99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    + Add
  • Guardant Health, Inc.GH · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $24.1 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $24.1 B (Oct 28, 2026) · revenue $982 M (year to December 2025)
    99 of 100 (industry or sector 50 + size 29 + country 15 + figures on file 5)
    + Add
  • Illumina, Inc.ILMN · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $40.7 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $40.7 B (Oct 26, 2026) · revenue $4.3 B (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    + Add
  • IDEXX Laboratories, Inc.IDXX · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $41.5 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $41.5 B (Oct 6, 2026) · revenue $4.3 B (year to December 2025)
    98 of 100 (industry or sector 50 + size 28 + country 15 + figures on file 5)
    + Add
  • Waters CorporationWAT · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $44.8 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $44.8 B (Oct 27, 2026) · revenue $3.2 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • IQVIA Holdings Inc.IQV · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $45.1 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $45.1 B (Oct 27, 2026) · revenue $16.3 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • Medpace Holdings, Inc.MEDP · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $19.0 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $19.0 B (Oct 30, 2026) · revenue $2.5 B (year to December 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • Agilent Technologies, Inc.A · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $48.8 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $48.8 B (Oct 19, 2026) · revenue $6.9 B (year to October 2025)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • Revvity, Inc.RVTY · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $17.6 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $17.6 B (Oct 23, 2026) · revenue $2.9 B (year to December 2025)
    96 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    + Add
  • Charles River Laboratories International, Inc.CRL · 🇺🇸 USA
    Same industry: Diagnostics and Research · Similar size: $17.2 B market cap against $29.9 B · Same country: USA · Ratios of the last two fiscal years on file
    Market cap $17.2 B (Oct 28, 2026) · revenue $4.0 B (year to December 2025)
    96 of 100 (industry or sector 50 + size 26 + country 15 + figures on file 5)
    + Add

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

DexCom, Inc. side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureDexCom, Inc.base
DXCM · 🇺🇸 US
Percentile in Healthcare
Percentile in USA
Group median
Size
Market cap (Better neither way: ranked highest first)$29.9 BOct 22, 2026 · Market dataonly one with it$29.9 B—
Revenue (Better neither way: ranked highest first)$4.7 BFY2025 · SEConly one with it$4.7 B—
Net income (Higher is better)$836 MFY2025 · SEConly one with it$836 M—
Employees (Better neither way: ranked highest first)11,100December 31, 2025 · Profileonly one with it11,100—
Growth
Revenue growth (Higher is better)+15.6%FY2025 · SEConly one with it60th72nd+15.6%—
Revenue growth, 3 years a year (Higher is better)+17.0%FY2025 · SEConly one with it68th82nd+17.0%—
Earnings per share growth (Higher is better)+47.2%FY2025 · SEConly one with it75th80th+47.2%—
Margins and returns
Gross margin (Higher is better)60.1%FY2025 · SEConly one with it53rd74th60.1%—
Operating margin (Higher is better)19.6%FY2025 · SEConly one with it88th85th19.6%—
Net margin (Higher is better)17.9%FY2025 · SEConly one with it89th87th17.9%—
Free cash flow margin (Higher is better)23.1%FY2025 · SEConly one with it92nd91st23.1%—
Return on equity (Higher is better)34.5%FY2025 · SEConly one with it95th93rd34.5%—
Valuation
P/E ratio (Better neither way: ranked highest first)30.2×price Oct 22, 2026 · Market dataonly one with it51st72nd30.2×—
Price to sales (Better neither way: ranked highest first)5.9×price Oct 22, 2026 · Market dataonly one with it61st80th5.9×—
Price to book (Better neither way: ranked highest first)10.9×price Oct 22, 2026 · Market dataonly one with it85th90th10.9×—
Free cash flow yield (Higher is better)3.6%price Oct 22, 2026 · Market dataonly one with it81st57th3.6%—
Financial strength
Interest cover (Higher is better)63.8×FY2025 · SEConly one with it99th97th63.8×—
Scorecard
Scorecard (Higher is better)18 of 24FY2025 · Scorecardonly one with it75% passed—
Valuation checks (Higher is better)1 of 6FY2025 · Scorecardonly one with it17% passed—
Growth checks (Higher is better)6 of 6FY2025 · Scorecardonly one with it100% passed—
Profitability checks (Higher is better)5 of 5FY2025 · Scorecardonly one with it100% passed—
Financial health checks (Higher is better)4 of 4FY2025 · Scorecardonly one with it100% passed—
Shareholder returns checks (Higher is better)2 of 3FY2025 · Scorecardonly one with it67% passed—
Ownership
Held by institutions (Better neither way: ranked highest first)98.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it98.2%—
Institutions holding (Better neither way: ranked highest first)1,0542026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are inonly one with it1,054—
Institutional holding, change over the quarter (Better neither way: ranked highest first)+8.2 pp2026-Q2 against 2026-Q1 · 13Fonly one with it+8.2 pp—
Dividends
Shareholder yield (Higher is better)1.7%FY2025 · SEConly one with it43rd30th1.7%—

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = DexCom, Inc.: SEC closing prices (fails-to-deliver files) times the shares on the latest 10-K or 10-Q cover.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
DexCom, Inc.19.6%FY2025
88th percentile in Healthcaremedian -7.7%, 674 companies
85th percentile in USAmedian 3.5%, 2,594 companies

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$1.2 B$2.3 B$3.5 B$4.7 B20102012201420162018202020222024DexCom, Inc. $4.7 B

Rank in the group

Ranks need two fiscal years with the figure for at least two of these companies.

Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearDexCom, Inc.
2025$4.7 BSEC
2024$4.0 BSEC
2023$3.6 BSEC
2022$2.9 BSEC
2021$2.4 BSEC
2020$1.9 BSEC
2019$1.5 BSEC
2018$1.0 BSEC
2017$719 MSEC
2016$573 MSEC
2015$402 MSEC
2014$259 MSEC

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.